Glutamine supplement may speed digestion in preemies
NCT ID NCT00213668
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving glutamine (a dietary supplement) to premature babies helps them digest food faster and reduces the time they need IV nutrition. Forty babies born at 30-33 weeks and free of acute illness were randomly assigned to receive either glutamine or a control supplement. Researchers measured how quickly food left the stomach and how long it took to reach full feeding by mouth.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- glutamine (a dietary supplement)
- What this could lead to
- If glutamine speeds up digestion, it could help premature babies get off IV nutrition sooner and go home earlier.
- What could go wrong
- This is a small, early-stage study (40 babies) looking at digestion markers, not long-term health. Results may not change standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Started
-
Apr 2002
- Finished
-
Dec 2005
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
2 to 10 days
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Premature neonates aged 30-33 weeks of gestational age * Aged at least 2 days and no more than 10 days * Free of acute illness * Written informed consent is obtained from the parent prior to enrolment. Exclusion Criteria: * Premature infants with respiratory (fraction of inspired oxygen \[FiO2\] \> 30%), or cardiovascular, liver, intestinal or acute diseases * Premature infants with congenital syndrome
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Enteral feeding are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU-Rouen
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.